MedPath

北京京丰制药集团有限公司

Ownership
-
Established
2002-03-06
Employees
-
Market Cap
-
Website
http://www.jfzyao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

42

NMPA:42

Drug Approvals

Metformin Hydrochloride Tablets

Product Name
盐酸二甲双胍片
Approval Number
国药准字H11021518
Approval Date
Nov 5, 2024
NMPA

Cefalexin Tablets

Product Name
头孢氨苄片
Approval Number
国药准字H11020118
Approval Date
Oct 22, 2024
NMPA

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H11020117
Approval Date
Sep 2, 2024
NMPA

Cefradine Capsules

Product Name
头孢拉定胶囊
Approval Number
国药准字H11020119
Approval Date
Sep 2, 2024
NMPA

Isosorbide Mononitrate Tablets

Product Name
单硝酸异山梨酯片
Approval Number
国药准字H20093525
Approval Date
Apr 3, 2024
NMPA

Cefaclor Dispersible Tablets

Product Name
头孢克洛分散片
Approval Number
国药准字H20093539
Approval Date
Apr 3, 2024
NMPA

Hydrotalcite Chewable Tablets

Product Name
铝碳酸镁咀嚼片
Approval Number
国药准字H20093606
Approval Date
Jan 4, 2024
NMPA

Cefuroxime Axetil Tablets

Product Name
头孢呋辛酯片
Approval Number
国药准字H20143017
Approval Date
Oct 13, 2023
NMPA

Acarbose Tablets

Product Name
阿卡波糖片
Approval Number
国药准字H20233870
Approval Date
Jun 30, 2023
NMPA

Metformin Hydrochloride Enteric-coated Tablets

Product Name
盐酸二甲双胍肠溶片
Approval Number
国药准字H20123202
Approval Date
Dec 15, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.